EUVIMEDEUVIMED entdecken
Crossref

Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst

Sineenat Sripattanakul, Piyasiri Chueakwon, Le Thi Thuy Trinh, Rung-Yi Lai

Enzyme and Microbial Technology · 2025

DOI: 10.1016/j.enzmictec.2025.110682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Enzyme and Microbial Technology, 2025. Verfasst von Sineenat Sripattanakul und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand; Office of Research Administration, …. Hauptthemen laut MEDLINE: Escherichia coli, Niacin, Pyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Suranaree University of Technology, Thailand Science Research and Innovation, National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinic acid, a bioactive form of niacin (vitamin B3), is an essential nutrient involved in various metabolic pathways. Its deficiency can lead to severe health issues, emphasizing the need for effective production methods. Traditional chemical methods for synthesizing nicotinic acid often require harsh reaction conditions and produce environmentally hazardous byproducts. This has prompted increasing interest in more sustainable biocatalytic alternatives. In this study, we investigated the bioconversion of 3-methylpyridine (3-MP) to nicotinic acid using resting cells of recombinant Escherichia coli expressing enzymes from Pseudomonas putida mt-2. Through systematic optimization, E. coli MG1655 RARE cells co-overexpressing xylene monooxygenase (XMO: XylM and its reductase XylA) and benzyl alcohol dehydrogenase (XylB) achieved efficient biotransformation of 9 mM 3-MP to 8.28 ± 0.35 mM nicotinic acid within 12 hours, corresponding to a yield of 92.0 % ± 3.9 %. This work presents a streamlined biocatalytic route for nicotinic acid synthesis and offers a foundation for further metabolic engineering of microbial production systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliNiacinPyridinesPseudomonas putidaBiocatalysisMetabolic EngineeringBiotransformationRecombinant ProteinsBacterial Proteins

Stichwörter der Autor:innen

3-MethylpyridineNiacinNicotinic acidWhole-cell biocatalystXylene monooxygenase

Substanzen

NiacinPyridinesRecombinant ProteinsBacterial Proteins

Autor:innen und Institutionen

  • School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand; Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.
  • School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand.
  • School of Chemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand. Electronic address: rylai@sut.ac.th.

Förderung

  • Suranaree University of Technology
  • Thailand Science Research and Innovation
  • National Research Council of Thailand

Zitieren

APA

Sripattanakul, S., Chueakwon, P., Trinh, L. T. T., & Lai, R. Y. (2025). Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst. Enzyme and Microbial Technology. https://doi.org/10.1016/j.enzmictec.2025.110682

Vancouver

Sripattanakul S, Chueakwon P, Trinh LTT, Lai RY. Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst. Enzyme and Microbial Technology. 2025. doi:10.1016/j.enzmictec.2025.110682

BibTeX
@article{Sripattanakul2025,
  author = {Sripattanakul, Sineenat and Chueakwon, Piyasiri and Trinh, Le Thi Thuy and Lai, Rung-Yi},
  title = {Nicotinic acid production from 3-methylpyridine by E. coli whole-cell biocatalyst},
  journal = {Enzyme and Microbial Technology},
  year = {2025},
  doi = {10.1016/j.enzmictec.2025.110682}
}
Kostenlos starten →